Clinical Trial Update: FREEDOM - M: Oral Treprostinil as Monotherapy for the Treatment of Pulmonary Arterial Hypertension (PAH) [Phase 3]

View source ↗

Summary

Phase 3 trial update for oral treprostinil as monotherapy in pulmonary arterial hypertension (FREEDOM-M) completed with posted results in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension
• Pulmonary Hypertension

Drugs mentioned

• Treprostinil (oral, monotherapy) (treprostinil)

Snippet

Sponsor: United Therapeutics | Conditions: Pulmonary Hypertension | Phase 3 | Status: COMPLETED | Results posted: 2013-03-18